- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 2, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by HealthCentral referenced a study published in the March 2016 issue of The American Journal of Managed Care®(AJMC®). The study, “Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid Arthritis,” found that patients with rheumatoid arthritis reported a moderate rate of previous pneumococcal vaccination and a very low rate of the herpes zoster vaccination.
An article by Komando referenced a contributor piece published on AJMC.com, the website of AJMC. The article, “Contributor: Medication Adherence Is Not a Zero-Sum Game,” featured a contributor speaking on mitigating the high cost of prescription drugs in addressing getting patients to take their medications as advised.
An article from Specialty Pharmacy Continuum referenced an article published on AJMC’s sister site, The Center for Biosimilars®. The article, “Part 1: Biosimilars to Bring a Bumper Crop of Adalimumab Options,” provided specifics on each of the adalimumab biosimilar products that were upcoming in 2023 and why Europe may have different experiences than that of the United States.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
